This Week in Science

A team of Harvard University researchers reports in Science on its examination of insertion mutations into the EGFR exon 20 in non–small cell lung cancer. These mutations, the team notes, are associated with reduced sensitivity to tyrosine kinase inhibitors like gefitinib, erlotinib, and afatinib, which they confirmed in an in vitro study.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.